methotrexate has been researched along with Thromboembolism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H | 1 |
| Boleti, K; Darby, A; Nolan, L; Simmonds, P | 1 |
| Bendtzen, K | 1 |
| Goodnough, LT; Jones, PK; Manni, A; Pearson, OH; Saito, H | 1 |
| Fine, S; Pater, J; Paterson, AH; Paul, NA; Pritchard, KI; Zee, B | 1 |
| Dreicer, R; Loehrer, PJ; Messing, EM; Trump, DL | 1 |
1 review(s) available for methotrexate and Thromboembolism
| Article | Year |
|---|---|
[Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis].
Topics: Anticoagulants; Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Drug Therapy, Combination; Gene Frequency; Humans; Maintenance Chemotherapy; Methotrexate; Pharmacokinetics; Polymorphism, Genetic; Precision Medicine; Replication Protein C; Thromboembolism; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin | 2013 |
2 trial(s) available for methotrexate and Thromboembolism
| Article | Year |
|---|---|
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Incidence; Methotrexate; Tamoxifen; Thromboembolism | 1996 |
Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Thromboembolism; Urinary Bladder Neoplasms; Vinblastine | 1990 |
3 other study(ies) available for methotrexate and Thromboembolism
| Article | Year |
|---|---|
The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Thromboembolism | 2011 |
Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
Topics: Adalimumab; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Immunogenetic Phenomena; Immunosuppressive Agents; Immunotherapy; Incidence; Methotrexate; Risk Factors; Thromboembolism; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prednisone; Thromboembolism; Vincristine | 1984 |